Topics

CC-Pharming And iBio Expand Chinese Rituximab Venture

03:12 EDT 13 Sep 2019 | SCRIP

A year after their initial tie-up, US plant-based tech firm iBio Inc. and China’s CC-Pharming Ltd are expanding their collaboration...

      

Related Stories

 

Original Article: CC-Pharming And iBio Expand Chinese Rituximab Venture

NEXT ARTICLE

More From BioPortfolio on "CC-Pharming And iBio Expand Chinese Rituximab Venture"

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...